Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Pancreatic Adenocarcinoma by Combining Contrast Agent and Gemitabine Under Sonification

NCT01674556 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT01674556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01674556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Pancreatic Adenocarcinoma by Combining Contrast Agent and Gemitabine Under Sonification
Lead sponsor
Haukeland University Hospital
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2012
Completion date
January 31, 2015
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma